发明名称 |
CELLULAR COMPOSITIONS FOR TISSUE ENGINEERING |
摘要 |
Cell compositions for tissue engineering are provided which contain a population of autologous, minimally passaged dermal fibroblasts in combination with a tissue engineering matrix or scaffold, or material forming a matrix or scaffold. In one embodiment, the population of fibroblasts is genetically engineered to secrete a therapeutic protein in an amount effective to induce tissue growth or tissue repair when the cell composition is transplanted into a subject in need thereof. For example, the therapeutic protein can be a bone morphogenic protein when the tissue to be treated is bone tissue. A preferred bone morphogenic protein is BMP-2. |
申请公布号 |
US2014178346(A1) |
申请公布日期 |
2014.06.26 |
申请号 |
US201314140420 |
申请日期 |
2013.12.24 |
申请人 |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
发明人 |
Byrne James A.;Wang Jeffrey C. |
分类号 |
A61K35/32 |
主分类号 |
A61K35/32 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of stimulating bone formation in the body, the method comprising:
(a) genetically modifying autologus cells to express bone formation stimulating proteins; and (b) implanting said genetically modified autologus cells in a location in a body of a patient identified for bone formation to induce bone formation. |
地址 |
Oakland CA US |